-
Loading metrics
Open Access
Peer-reviewed
Research Article
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial
-
Zoe Moodie ,
Roles Data curation, Formal analysis, Methodology, Software, Writing – original draft, Writing – review & editing
* E-mail: zoe@fredhutch.org
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
⨯ -
Erica Andersen-Nissen,
Roles Data curation, Formal analysis, Methodology, Writing – original draft, Writing – review & editing
Affiliations Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa
⨯ -
Nicole Grunenberg,
Roles Conceptualization, Investigation, Writing – review & editing
Current address: PATH, Seattle, Washington, United States of America
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
⨯ -
One B. Dintwe,
Roles Investigation, Writing – review & editing
Affiliations Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa
⨯ -
Faatima Laher Omar,
Roles Investigation, Writing – review & editing
Affiliation Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa
⨯ -
Jia J. Kee,
Roles Data curation, Formal analysis, Software, Writing – review & editing
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
⨯ -
Linda-Gail Bekker,
Roles Investigation, Writing – review & editing
Affiliation Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
⨯ -
Fatima Laher,
Roles Investigation, Writing – review & editing
Affiliation Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
⨯ -
Nivashnee Naicker,
Roles Investigation, Writing – review & editing
Affiliation Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa; and Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa
⨯ -
Ilesh Jani,
Roles Investigation, Writing – review & editing
Affiliation Instituto Nacional de Saude, Maputo, Mozambique
⨯ -
Nyaradzo M. Mgodi,
Roles Investigation, Writing – review & editing
Affiliation Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe
⨯ -
Portia Hunidzarira,
Roles Investigation, Writing – review & editing
Affiliation Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe
⨯ -
Modulakgota Sebe,
Roles Investigation, Writing – review & editing
Affiliation Aurum Institute, Tembisa, Gauteng, South Africa
⨯ -
Maurine D. Miner,
Roles Data curation, Writing – review & editing
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
⨯ -
Laura Polakowski,
Roles Investigation, Writing – review & editing
Affiliation DAIDS, NIAID, NIH, Bethesda, Maryland, United States of America
⨯ -
Shelly Ramirez,
Roles Investigation, Project administration, Writing – review & editing
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
⨯ -
Michelle Nebergall,
Roles Investigation, Project administration, Writing – review & editing
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
⨯ -
Simbarashe Takuva,
Roles Investigation, Project administration, Writing – review & editing
Current address: School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
⨯ -
Lerato Sikhosana,
Roles Investigation, Writing – review & editing
Current address: National Health Laboratory Service, Johannesburg, South Africa
Affiliation Hutchinson Centre Research Institute of South Africa, Johannesburg, South Africa
⨯ -
Jack Heptinstall,
Roles Investigation, Writing – review & editing
Affiliation Department of Surgery, Duke University, Durham, North Carolina, United States of America
⨯ -
Kelly E. Seaton,
Roles Investigation, Writing – review & editing
Affiliation Department of Surgery, Duke University, Durham, North Carolina, United States of America
⨯ -
Stephen De Rosa,
Roles Investigation, Writing – review & editing
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
⨯ -
Carlos A. Diazgranados,
Roles Conceptualization, Writing – review & editing
Current address: Bill & Melinda Gates Foundation, Seattle, Washington, United States of America
Affiliation Formerly Sanofi-Pasteur, Swiftwater, Pennsylvania, Pennsylvania, United States of America
⨯ - Marguerite Koutsoukos,
-
Olivier Van Der Meeren,
Roles Conceptualization, Writing – review & editing
Affiliation Previously GSK, Rixensart, Belgium
⨯ -
Susan W. Barnett,
Roles Conceptualization, Writing – review & editing
Affiliation Bill & Melinda Gates Foundation, Seattle, Washington, United States of America
⨯ -
Niranjan Kanesa-thasan,
Roles Conceptualization, Writing – review & editing
Current address: Icosavax, Inc., Seattle, Washington, United States of America
Affiliation Formerly GSK, Rockville, Maryland, United States of America
⨯ -
James G. Kublin,
Roles Writing – review & editing
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
⨯ -
Georgia D. Tomaras,
Roles Conceptualization, Funding acquisition, Methodology, Writing – review & editing
Affiliation Department of Surgery, Duke University, Durham, North Carolina, United States of America
⨯ -
M. Juliana McElrath,
Roles Conceptualization, Funding acquisition, Writing – review & editing
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
⨯ -
Lawrence Corey,
Roles Conceptualization, Funding acquisition, Writing – review & editing
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
⨯ -
Kathryn Mngadi ,
Contributed equally to this work with: Kathryn Mngadi, Paul Goepfert
Roles Investigation, Writing – original draft, Writing – review & editing
Affiliation Aurum Institute, Tembisa, Gauteng, South Africa
⨯ -
Paul Goepfert ,
Contributed equally to this work with: Kathryn Mngadi, Paul Goepfert
Roles Investigation, Writing – original draft, Writing – review & editing
Affiliation Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
⨯ - [ ... ],
-
on behalf of the HVTN 107 Protocol Team
¶Membership of HVTN 107 Protocol Team is provided in the Acknowledgements.
⨯ - [ view all ]
- [ view less ]
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial
- Zoe Moodie,
- Erica Andersen-Nissen,
- Nicole Grunenberg,
- One B. Dintwe,
- Faatima Laher Omar,
- Jia J. Kee,
- Linda-Gail Bekker,
- Fatima Laher,
- Nivashnee Naicker,
- Ilesh Jani
-
- Published: March 19, 2024
- https://doi.org/10.1371/journal.pmed.1004360